Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 5
2004 11
2005 8
2006 18
2007 13
2008 18
2009 25
2010 26
2011 31
2012 43
2013 52
2014 66
2015 70
2016 61
2017 91
2018 105
2019 130
2020 71
Text availability
Article attribute
Article type
Publication date

Search Results

764 results
Results by year
Filters applied: . Clear all
Page 1
Methylenetetrahydrofolate reductase and psychiatric diseases.
Wan L, Li Y, Zhang Z, Sun Z, He Y, Li R. Wan L, et al. Among authors: He Y. Transl Psychiatry. 2018 Nov 5;8(1):242. doi: 10.1038/s41398-018-0276-6. Transl Psychiatry. 2018. PMID: 30397195 Free PMC article. Review.
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH; ACT IV trial investigators. Weller M, et al. Among authors: He Y. Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23. Lancet Oncol. 2017. PMID: 28844499 Free article. Clinical Trial.
Toll-like receptors TLR2 and TLR4 block the replication of pancreatic β cells in diet-induced obesity.
Ji Y, Sun S, Shrestha N, Darragh LB, Shirakawa J, Xing Y, He Y, Carboneau BA, Kim H, An D, Ma M, Oberholzer J, Soleimanpour SA, Gannon M, Liu C, Naji A, Kulkarni RN, Wang Y, Kersten S, Qi L. Ji Y, et al. Among authors: He Y. Nat Immunol. 2019 Jun;20(6):677-686. doi: 10.1038/s41590-019-0396-z. Epub 2019 May 20. Nat Immunol. 2019. PMID: 31110312 Free PMC article.
LncRNAs regulate the cytoskeleton and related Rho/ROCK signaling in cancer metastasis.
Tang Y, He Y, Zhang P, Wang J, Fan C, Yang L, Xiong F, Zhang S, Gong Z, Nie S, Liao Q, Li X, Li X, Li Y, Li G, Zeng Z, Xiong W, Guo C. Tang Y, et al. Among authors: He Y. Mol Cancer. 2018 Apr 4;17(1):77. doi: 10.1186/s12943-018-0825-x. Mol Cancer. 2018. PMID: 29618386 Free PMC article. Review.
Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane.
Kaufman PA, Awada A, Twelves C, Yelle L, Perez EA, Velikova G, Olivo MS, He Y, Dutcus CE, Cortes J. Kaufman PA, et al. Among authors: He Y. J Clin Oncol. 2015 Feb 20;33(6):594-601. doi: 10.1200/JCO.2013.52.4892. Epub 2015 Jan 20. J Clin Oncol. 2015. PMID: 25605862 Free PMC article. Clinical Trial.
High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells.
Li J, He Y, Hao J, Ni L, Dong C. Li J, et al. Among authors: He Y. Front Immunol. 2018 Dec 18;9:2981. doi: 10.3389/fimmu.2018.02981. eCollection 2018. Front Immunol. 2018. PMID: 30619337 Free PMC article.
764 results
Jump to page
Feedback